Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
164 confirmed dead after two major earthquakes strike Venezuela
Europeans told to protect themselves as deadly heatwave takes its toll
Trump asks Congress for more funds to fight Iran, defying rebuke on war powers
Magnitude 6.9 quake strikes Japan's northeast, no tsunami warning
US, Iran at odds on nuclear inspections, frozen assets in deal to end war
